Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

C3 activator in agammaglobulinemia.

S Nakajima, K Nihei, Y Hyodo

International Archives of Allergy and Applied Immunology

|January 1, 1978

Summary

Levels of complement component 3 (C3) activators are elevated in patients with agammaglobulinemia, suggesting the alternative complement pathway compensates for antibody deficiencies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Multiple intra-articular injections with adipose-derived stem cells for knee osteoarthritis cause severe arthritis with anti-histone H2B antibody production.

Regenerative therapy·2023

Same author

Optimisation of Radiation Therapy in Bladder Preservation Therapy for Patients With Clinical Stage T2N0M0 Bladder Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022

Same author

Statistical mechanical determination of nanocluster size distributions in the phase coexistence region of a first order phase transition from the isotherms of DMPC monolayers at the air-water interface.

Physical chemistry chemical physics : PCCP·2021

Same author

Antifungal Cyclodepsipeptides, W493 A and B, from Fusarium sp.: Isolation and Structural Determination.

Bioscience, biotechnology, and biochemistry·2016

Same author

Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.

Endoscopy·2011

Same author

Submucosal tumor appearance is a useful endoscopic predictor of early primary-site recurrence after definitive chemoradiotherapy for esophageal squamous cell carcinoma.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2010

Area of Science:

Immunology
Complement System Biology

Background:

Agammaglobulinemia is a primary immunodeficiency characterized by defective B-cell development and antibody production.
The complement system, a crucial part of innate immunity, can be activated via alternative, classical, and lectin pathways.

Purpose of the Study:

To investigate complement system activation in patients with agammaglobulinemia.
To explore the potential compensatory role of the alternative complement pathway in the absence of effective antibody production.

Main Methods:

Serum samples were collected from patients diagnosed with agammaglobulinemia and age-matched healthy controls.
Levels of C3 activator, a key component of the alternative complement pathway, were measured in all serum samples.

Main Results:

Significantly higher levels of C3 activator were observed in the sera of patients with agammaglobulinemia compared to healthy controls.
This finding indicates increased activation of the alternative complement pathway in individuals lacking antibody production.

Conclusions:

The alternative complement pathway may act as a compensatory mechanism in agammaglobulinemia to mitigate the functional deficit caused by the lack of antibodies.
Further research is warranted to elucidate the precise role and therapeutic potential of alternative pathway activation in managing infections associated with agammaglobulinemia.

Related Experiment Videos